OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator
Qingqing Xiao, Xiaotong Li, Chang Liu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 8, pp. 3503-3517
Open Access | Times Cited: 29
Qingqing Xiao, Xiaotong Li, Chang Liu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 8, pp. 3503-3517
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Multifunctional nanoparticle-mediated combining therapy for human diseases
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 125
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 125
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
Current research trends of nanomedicines
Qiuyue Liu, Jiahui Zou, Zhongjian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4391-4416
Open Access | Times Cited: 82
Qiuyue Liu, Jiahui Zou, Zhongjian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4391-4416
Open Access | Times Cited: 82
Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective
Jieyu Liu, Yinan Bai, Yinggang Li, et al.
EBioMedicine (2024) Vol. 107, pp. 105301-105301
Open Access | Times Cited: 79
Jieyu Liu, Yinan Bai, Yinggang Li, et al.
EBioMedicine (2024) Vol. 107, pp. 105301-105301
Open Access | Times Cited: 79
Approved Nanomedicine against Diseases
Yuanchao Jia, Yuxin Jiang, Yonglong He, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 774-774
Open Access | Times Cited: 59
Yuanchao Jia, Yuxin Jiang, Yonglong He, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 774-774
Open Access | Times Cited: 59
Lipid carriers for mRNA delivery
Wanting Zhang, Yuxin Jiang, Yonglong He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 10, pp. 4105-4126
Open Access | Times Cited: 67
Wanting Zhang, Yuxin Jiang, Yonglong He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 10, pp. 4105-4126
Open Access | Times Cited: 67
Multifunctional biodegradable nanoplatform based on oxaliplatin prodrug cross-linked mesoporous polydopamine for enhancing cancer synergetic therapy
Ping Sun, Zimu Li, Dan Zhang, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 1, pp. 108346-108346
Open Access | Times Cited: 32
Ping Sun, Zimu Li, Dan Zhang, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 1, pp. 108346-108346
Open Access | Times Cited: 32
Thrombospondin-1-mediated crosstalk between autophagy and oxidative stress orchestrates repair of blast lung injury
Lin Zhang, Yongheng Wang, Linqiang Tian, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167026-167026
Open Access | Times Cited: 8
Lin Zhang, Yongheng Wang, Linqiang Tian, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167026-167026
Open Access | Times Cited: 8
Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment
Yonglong He, Wanting Zhang, Qingqing Xiao, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 6, pp. 817-837
Open Access | Times Cited: 37
Yonglong He, Wanting Zhang, Qingqing Xiao, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 6, pp. 817-837
Open Access | Times Cited: 37
Approved delivery strategies for biopharmaceuticals
Makhloufi Zoulikha, Zhongjian Chen, Jun Wu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 2, pp. 110225-110225
Closed Access | Times Cited: 7
Makhloufi Zoulikha, Zhongjian Chen, Jun Wu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 2, pp. 110225-110225
Closed Access | Times Cited: 7
Pulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation
Yi Yang, Makhloufi Zoulikha, Qingqing Xiao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4607-4620
Open Access | Times Cited: 15
Yi Yang, Makhloufi Zoulikha, Qingqing Xiao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4607-4620
Open Access | Times Cited: 15
Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1
Xin Zang, Xiaoyu He, Cheng-mei Xiao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Xin Zang, Xiaoyu He, Cheng-mei Xiao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Drug delivery for platinum therapeutics
Hui Liu, Jiahui Zou, Xiaotong Li, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 503-523
Closed Access
Hui Liu, Jiahui Zou, Xiaotong Li, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 503-523
Closed Access
siRNA micelleplexes-mediated glutamine metabolism re-engineering for vascular normalization-boosted photo-immunotherapy
Yunfei Yi, Zhangwen Peng, Yuanqi Liu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Yunfei Yi, Zhangwen Peng, Yuanqi Liu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Interplay Between TGFβ1 Signaling and Cancer-Testis Antigen MAGEB2: A New Thorn in Cancer’s Side?
Ashley Colemon, Carlan V. Romney, Angelle D. Jones, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2448-2448
Open Access
Ashley Colemon, Carlan V. Romney, Angelle D. Jones, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2448-2448
Open Access
Oral Delivery Strategies for Biological Drugs
Huiling Zeng, Mingyang Ma, Xiuju Peng, et al.
Small Methods (2025)
Closed Access
Huiling Zeng, Mingyang Ma, Xiuju Peng, et al.
Small Methods (2025)
Closed Access
Advancements of nanoscale drug formulations for combination treatment of colorectal cancer
Liqi Li, Maohua Chen, Rui L. Reis, et al.
International Journal of Pharmaceutics (2025), pp. 125508-125508
Closed Access
Liqi Li, Maohua Chen, Rui L. Reis, et al.
International Journal of Pharmaceutics (2025), pp. 125508-125508
Closed Access
Pure drug nanomedicines - where we are?
Yaoyao Lai, Bing Xie, Wanting Zhang, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 4, pp. 385-409
Closed Access
Yaoyao Lai, Bing Xie, Wanting Zhang, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 4, pp. 385-409
Closed Access
Microglia-targeting nanosystems that cooperatively deliver Chinese herbal ingredients alleviate behavioral and cognitive deficits in Alzheimer’s disease model mice
Peng Zhou, Chao Quan, Chen Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Peng Zhou, Chao Quan, Chen Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Drug Delivery and Therapy Strategies for Osteoporosis Intervention
Mingyang Ma, Huiling Zeng, Pei Yang, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6652-6652
Open Access | Times Cited: 9
Mingyang Ma, Huiling Zeng, Pei Yang, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6652-6652
Open Access | Times Cited: 9
Exosome-biomimetic nanocarriers for oral drug delivery
Fengjie Liu, Fansu Meng, Zhenjiang Yang, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 9, pp. 109335-109335
Closed Access | Times Cited: 7
Fengjie Liu, Fansu Meng, Zhenjiang Yang, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 9, pp. 109335-109335
Closed Access | Times Cited: 7
Integrated analysis of multiple transcriptomic approaches and machine learning integration algorithms reveals high endothelial venules as a prognostic immune-related biomarker in bladder cancer
Jinge Zhang, Yuan Huang, Xing Tan, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112184-112184
Closed Access | Times Cited: 2
Jinge Zhang, Yuan Huang, Xing Tan, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112184-112184
Closed Access | Times Cited: 2
The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research
Aurélie Moniot, Christophe Schneider, Laure Chardin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Aurélie Moniot, Christophe Schneider, Laure Chardin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Cocrystal@protein-anchoring nanococktail for combinatorially treating multidrug-resistant cancer
Jiahui Zou, Xuyang Xing, Chao Teng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4509-4525
Open Access | Times Cited: 2
Jiahui Zou, Xuyang Xing, Chao Teng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4509-4525
Open Access | Times Cited: 2
DPH Probe Method for Liposome-Membrane Fluidity Determination
Wei He
Methods in molecular biology (2023), pp. 241-244
Closed Access | Times Cited: 5
Wei He
Methods in molecular biology (2023), pp. 241-244
Closed Access | Times Cited: 5
